Co‐diagnoses of acute myeloid leukaemia and COVID ‐19: presentation and management implicationsCase Report Published on 2020-08-252022-10-29 Journal: Respirology Case Reports [Category] COVID-19, [키워드] acute myeloid leukaemia acute respiratory syndrome AML Clinical course coronavirus coronavirus disease COVID COVID‐19 COVID‐19 diagnose Immunocompromise Immunocompromised patient Immunocompromised patients Immunosuppression implication Infection knowledge management Mild neoplasm Patient remained respiratory SARS‐CoV‐2 SARS‐CoV‐2 infection SARS‐CoV‐2 systemic symptom [DOI] 10.1002/rcr2.650 PMC 바로가기 [Article Type] Case Report
Impact of diabetes on COVID-19-related in-hospital mortality: a retrospective study from Northern ItalyOriginal Article Published on 2020-08-102022-10-30 Journal: Journal of Endocrinological Investigation [Category] COVID-19, MERS, SARS, [키워드] age C-reactive protein cardiovascular disease chronic obstructive collected comorbid condition conducted confounding variables coronavirus COVID-19 death diabete diabetes evaluate evaluate the effect hospital Hospitalized hypertension Impact In-hospital in-hospital mortality Intensive Italy Laboratory lactic dehydrogenase Logistic regression lombardy male medical record Mortality multivariable model neoplasm occurred Older age Patient patients pulmonary disease relative Result retrospective Retrospective study SARS-CoV-2 single center single-center study Surveillance the patient was performed with COVID-19 [DOI] 10.1007/s40618-020-01382-7 PMC 바로가기 [Article Type] Original Article
ENDOCRINOLOGY IN THE TIME OF COVID-19: Clinical management of neuroendocrine neoplasms (NENs)Clinical Practice Guidance Published on 2020-08-092022-10-31 Journal: European Journal of Endocrinology [Category] COVID-19, MERS, [키워드] Chemotherapy clinical develop diagnosed disease Effect Follow-up functional genetic disorder growth Immunotherapy indolent interferon-alpha intestine life-threatening lung management medullary thyroid carcinoma Mild neoplasm neuroendocrine pancreas Pandemics Patient patients presenting receiving risk severity Surveillance Symptom syndrome targeted therapy therapy treated Treatment viral infection [DOI] 10.1530/EJE-20-0424 PMC 바로가기 [Article Type] Clinical Practice Guidance
Special considerations in the management of adult patients with acute leukaemias and myeloid neoplasms in the COVID-19 era: recommendations from a panel of international expertsReview article Published on 2020-06-182022-10-05 Journal: The Lancet. Haematology [Category] SARS, 유전자 메커니즘, [키워드] acute respiratory syndrome Care caused change clinical trial complex coronavirus country COVID-19 COVID-19 pandemic General population global public health health-care highlight International limitations management measure Multiple neoplasm observation outcome Patient patients Patients with cancer Post-infection recommendation supportive care [DOI] 10.1016/S2352-3026(20)30205-2 [Article Type] Review article
Cancer and SARS-CoV-2 Infection: Diagnostic and Therapeutic ChallengesReview Published on 2020-06-152022-10-31 Journal: Cancers [Category] COVID-19, [키워드] ACE2 receptor acute respiratory syndrome affected analyzed Betacoronavirus bevacizumab Cancer cancer patient challenge Chronic diseases Combination complications coronavirus COVID-19 cytokine Cytokines diagnostic drug Epidemiology expression Health Health status Immunosuppression immunosuppressive condition Infection inhibitors management neoplasm outcome pandemic pathogen Pathologies Patient patients Prognosis responsible risk factor SARS-CoV-2 SARS-COV-2 infection Support Therapies therapy Treatment Tumor viral disease virus [DOI] 10.3390/cancers12061581 PMC 바로가기 [Article Type] Review
Targeted therapies for cancer during the COVID-19 pandemic: a threat or a blessing?Editorial Published on 2020-06-102022-10-28 Journal: Pharmacogenomics [Category] COVID-19, SARS, [키워드] Cancer COVID-19 neoplasm SARS-CoV-2 targeted therapy therapy [DOI] 10.2217/pgs-2020-0059 PMC 바로가기 [Article Type] Editorial
The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trialLetter Published on 2020-06-082022-10-29 Journal: Trials [Category] COVID-19, SARS, [키워드] 1:1 48 hour 48 hours Activation Administered adverse event African age allergy analyzed Angola Antiviral approved ARMS Barcelona baseline blinded block Cerebrovascular disease chain chest X-ray childbearing chronic clinical care clinical trial co-morbidity conducted contraceptive method control group coronary disease cough country COVID-19 COVID-19 disease COVID-19 patient criteria Critical current CYP3A4 death detectable determine diagnosed with COVID-19 disease dissemination dose double-blind drug early treatment Efficacy element Endemic EudraCT excluded eye Factor Fever flow cytometry Follow-up visit Frequency Gabon global health groups history home visit Identified IgA IgA level IgG IgM immune response Immunity immunology immunomodulatory IMPROVE in vivo Infection Inflammatory inhibitor interfere investigator involved Isolation Ivermectin laboratory parameter Loa loa magnitude marker median Nasopharyngeal swab nasopharyngeal swab PCR negative neoplasm Nigeria no risk number objective outcome participant Patient Patient care patients PCR PCR cycle physical Placebo placebo group placebo-controlled Pneumonia positive positive SARS-CoV-2 PCR post-menopausal Potential pregnancy test pregnant women progression proportion protocol public health pulmonary random randomised randomised controlled trial randomization randomization list Randomized Rapid diagnostic test reaction receive recent recruited reduce Registered renal resident risk Ritonavir Safe Sample size SARS-CoV-2 SARS-CoV-2 RNA SARS-CoV-2-specific T cell secondary sequence Seroconversion severe disease severity single center single dose Spain status Study protocol subject submitted surgical Symptom symptom onset the patient the SARS-CoV-2 threshold transcriptomics Transmission transmission-blocking Travel treated patient treated patients Treatment treatment group Trial unblinding Viral load virus vulnerable population website with mild disease women [DOI] 10.1186/s13063-020-04421-z PMC 바로가기 [Article Type] Letter
A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 ( COVID ‐19) Pandemic: An International Collaborative GroupArticle Published on 2020-04-272023-07-01 Journal: The oncologist [Category] SARS, [키워드] coronavirus COVID‐19 Influenza neoplasm pandemic SARS‐CoV‐2 [DOI] 10.1634/theoncologist.2020-0213 PMC 바로가기
[Medical diagnosis and treatment strategies for malignant tumors of the digestive system during the outbreak of COVID-19]Article Published on 2020-03-232023-07-13 Journal: Zhonghua zhong liu za zhi [Chinese journal of oncology] [Category] SARS, [키워드] COVID-19 Diagnosis and treatment digestive system neoplasm [DOI] 10.3760/cma.j.cn112152-20200227-00141
Risk of Herpes Zoster Prior to and Following Cancer Diagnosis and Treatment: A Population-Based Prospective Cohort Study암 진단 및 치료 전후 대상 포진의 위험: 인구 기반 전향적 코호트 연구Article Published on 2019-06-052023-06-01 Journal: The Journal of Infectious Diseases [Category] 대상포진, 두창, 수두, 홍역, [키워드] Cancer Chemotherapy herpes zoster neoplasm [DOI] 10.1093/infdis/jiy625